Key considerations for clinical trials in psychopharmacology

被引：1

|

作者：

Zarate Jr, Carlos A. A. ^{[1
]}

机构：

[1] NIMH, Bethesda, MD 20892 USA

来源：

WORLD PSYCHIATRY | 2023年 / 22卷 / 01期

关键词：

KETAMINE;

D O I：

10.1002/wps.21061

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

收藏

页码：76 / 77

页数：2

相关论文

共 50 条

[31] Ethical considerations in clinical trials in Asia
Tanida, N
DRUG INFORMATION JOURNAL, 2002, 36 (01): : 41 - 49
[32] Considerations for the design of clinical trials for tinnitus
Tyler, Richard S.
Noble, William
Coelho, Claudia
ACTA OTO-LARYNGOLOGICA, 2006, 126 : 44 - 49
[33] STATISTICAL CONSIDERATIONS IN CLINICAL-TRIALS
MILLER, JP
MUSCLE & NERVE, 1990, 13 : S43 - S44
[34] ETHICAL CONSIDERATIONS IN CLINICAL-TRIALS
SHARPE, GJ
CLEARY, MJ
GALLETLY, DC
ANAESTHESIA AND INTENSIVE CARE, 1985, 13 (03) : 333 - 333
[35] Ethical considerations for nurses in clinical trials
Oberle, K
Allen, M
NURSING ETHICS, 2006, 13 (02) : 180 - 186
[36] STATISTICAL CONSIDERATIONS IN DESIGN OF CLINICAL TRIALS
CLARK, C
ACTA DERMATO-VENEREOLOGICA, 1971, 52 : 45 - &
[37] Design considerations for clinical trials in aphasia
Palmer, Rebecca
ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2020, 23 : 52 - 56
[38] Ethical Considerations in Decentralized Clinical Trials
Barbara E. Bierer
Sarah A. White
Journal of Bioethical Inquiry, 2023, 20 : 711 - 718
[39] Ethical Considerations in Clinical Trials in Asia
Noritoshi Tanida
Drug information journal : DIJ / Drug Information Association, 2002, 36 (1): : 41 - 49
[40] Considerations for clinical trials with cellular therapies
Champion, K. M.
HUMAN GENE THERAPY, 2016, 27 (11) : A3 - A3

← 1 2 3 4 5 →